Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-23 4:30 pm Purchase | 2024-12-19 | 13D | Marker Therapeutics, Inc. MRKR | New Enterprise Associates 16, L.P. | 1,625,678 15.200% | 554,250 (+51.73%) | Filing History |
| 2024-11-08 6:57 pm Unchanged | 2024-11-06 | 13D | Trevi Therapeutics, Inc. TRVI | New Enterprise Associates 16, L.P. | 15,074,080 18.700% | 0 (Unchanged) | Filing History |
| 2024-05-21 6:34 pm Purchase | 2024-05-07 | 13D | Trevi Therapeutics, Inc. TRVI | New Enterprise Associates 16, L.P. | 15,074,080 20.300% | 703,704 (+4.90%) | Filing History |
| 2024-05-17 6:25 pm Purchase | 2024-05-15 | 13D | Marker Therapeutics, Inc. MRKR | New Enterprise Associates 16, L.P. | 1,071,428 12.000% | 1,071,428 (New Position) | Filing History |
| 2024-05-13 7:09 pm Purchase | 2024-05-09 | 13D | Black Diamond Therapeutics, Inc. BDTX | New Enterprise Associates 16, L.P. | 4,546,947 8.100% | 1,098,190 (+31.84%) | Filing History |
| 2023-12-29 4:01 pm Sale | 2023-12-21 | 13D | Mirum Pharmaceuticals, Inc. MIRM | New Enterprise Associates 16, L.P. | 0 0.000% | -2,186,243 (Position Closed) | Filing History |
| 2023-06-23 2:32 pm Sale | 2023-06-13 | 13D | Mirum Pharmaceuticals, Inc. MIRM | New Enterprise Associates 16, L.P. | 2,186,243 5.800% | -2,000,000 (-47.78%) | Filing History |
| 2022-10-28 4:48 pm Unchanged | 2022-10-17 | 13D | Akouos, Inc. AKUS | New Enterprise Associates 16, L.P. | 4,294,207 11.600% | 0 (Unchanged) | Filing History |
| 2022-10-11 2:01 pm Purchase | 2022-09-21 | 13D | Allakos Inc. ALLK | New Enterprise Associates 16, L.P. | 6,147,260 7.300% | 6,147,260 (New Position) | Filing History |
| 2022-05-27 4:34 pm Sale | 2022-05-25 | 13D | Genocea Biosciences, Inc. GNCA | New Enterprise Associates 16, L.P. | 0 0.000% | -15,414,495 (Position Closed) | Filing History |
| 2022-04-25 5:04 pm Purchase | 2022-04-11 | 13D | Trevi Therapeutics, Inc. TRVI | New Enterprise Associates 16, L.P. | 14,370,376 42.500% | 6,580,526 (+84.48%) | Filing History |
| 2022-01-05 2:42 pm Sale | 2021-12-27 | 13D | Metacrine, Inc. MTCR | New Enterprise Associates 16, L.P. | 0 0.000% | -3,060,527 (Position Closed) | Filing History |
| 2021-11-02 09:09 am Purchase | 2021-10-18 | 13D | Trevi Therapeutics, Inc. TRVI | New Enterprise Associates 16, L.P. | 7,789,850 36.100% | 1,851,852 (+31.19%) | Filing History |
| 2021-04-13 7:08 pm Sale | 2020-07-24 | 13D | Genocea Biosciences, Inc. GNCA | New Enterprise Associates 16, L.P. | 15,414,495 26.300% | -1,558,333 (-9.18%) | Filing History |
| 2021-03-26 10:38 am Purchase | 2021-03-16 | 13D | Marker Therapeutics, Inc. MRKR | New Enterprise Associates 16, L.P. | 1,446,429 17.400% | 1,446,429 (New Position) | Filing History |
| 2021-03-10 8:35 pm Sale | 2019-11-29 | 13D | Allakos Inc. ALLK | New Enterprise Associates 16, L.P. | 0 0.000% | -2,266,675 (Position Closed) | Filing History |
| 2020-09-28 2:18 pm Purchase | 2020-09-22 | 13D | Metacrine, Inc. MTCR | New Enterprise Associates 16, L.P. | 3,060,527 11.800% | 3,060,527 (New Position) | Filing History |
| 2020-08-03 2:22 pm Purchase | 2020-07-24 | 13D | Genocea Biosciences, Inc. GNCA | New Enterprise Associates 16, L.P. | 16,972,828 48.700% | 8,004,211 (+89.25%) | Filing History |
| 2020-07-07 2:00 pm Purchase | 2020-06-30 | 13D | Akouos, Inc. AKUS | New Enterprise Associates 16, L.P. | 4,294,207 13.200% | 4,294,207 (New Position) | Filing History |
| 2020-04-16 4:26 pm Purchase | 2020-04-03 | 13D | Trevi Therapeutics, Inc. TRVI | New Enterprise Associates 16, L.P. | 5,937,998 33.300% | 1,499,436 (+33.78%) | Filing History |